Who are the main Silodosin API suppliers in India?
Several Indian manufacturers supply Silodosin Active Pharmaceutical Ingredient (API), catering to both domestic and international markets. Companies like Solara Active Pharma Sciences, Aristo Pharmaceuticals, and Ami Organics are noted suppliers of Silodosin API [1][2][3]. These suppliers play a crucial role in the global supply chain for medications containing Silodosin.
What is Silodosin used for?
Silodosin is a medication primarily used to treat the signs and symptoms of benign prostatic hyperplasia (BPH) [4]. BPH is a condition where the prostate gland enlarges, which can lead to difficulty urinating, frequent urination, and a weak stream [4]. Silodosin works by relaxing the muscles in the prostate and bladder neck, making it easier for urine to flow [4].
How do Silodosin suppliers ensure quality?
API suppliers in India generally adhere to stringent quality control measures and regulatory standards. This typically involves manufacturing under Good Manufacturing Practices (GMP) to ensure the purity, potency, and consistency of the API [5]. Regulatory bodies like the Indian FDA and international agencies often conduct inspections to verify compliance [5].
When does Silodosin patent exclusivity expire?
The patent exclusivity for Silodosin varies by region and specific patents. For instance, in the United States, key patents for Silodosin have already expired or are nearing expiration, allowing for the potential market entry of generic versions [6]. DrugPatentWatch.com tracks patent expiry dates for pharmaceuticals, providing detailed information on when exclusivity is expected to end [6].
Can generic Silodosin be manufactured before patent expiry?
Generally, the manufacture and sale of generic versions of a drug are restricted until the relevant patents expire or are successfully challenged. However, legal challenges to patents, such as Paragraph IV certifications in the U.S., can sometimes lead to earlier generic market entry if the challenge is successful [7].
What is the difference between Silodosin API and finished Silodosin drug products?
Silodosin API (Active Pharmaceutical Ingredient) is the pure chemical compound that has therapeutic effects. Finished Silodosin drug products, such as tablets or capsules, are the final dosage forms that patients take. The API is manufactured by specialized suppliers and then formulated into these finished products by pharmaceutical companies [1][4].
What are the risks associated with Silodosin API supply?
Risks in API supply can include quality control failures, supply chain disruptions, or regulatory non-compliance from manufacturers [5]. For companies relying on API suppliers, ensuring a stable and high-quality source is critical for uninterrupted production of finished drug products.
How do Silodosin prices fluctuate?
The price of Silodosin API can be influenced by factors such as manufacturing costs, raw material availability, competition among suppliers, and global demand [3][5]. As patents expire and generic competition increases, the price of both API and finished drug products typically decreases.
Who are the major competitors in the Silodosin market?
Key competitors in the Silodosin market include the originator company and generic manufacturers that produce both the API and the finished drug products. Takeda Pharmaceutical Company originally developed Silodosin [8]. Once patent protection wanes, numerous companies globally, including those in India, enter the market with generic offerings.
How is Silodosin regulated?
Silodosin, like all pharmaceuticals, is subject to strict regulation by health authorities in each country where it is marketed. In India, this is overseen by the Central Drugs Standard Control Organization (CDSCO), and in the U.S., by the Food and Drug Administration (FDA) [5][9]. These bodies approve the API manufacturing facilities and the finished drug products based on safety, efficacy, and quality data.
---
Sources:
1. "Silodosin API Manufacturers in India" - Solara Active Pharma Sciences, https://www.solara.com/product-profile/silodosin/
2. "Silodosin API" - Aristo Pharmaceuticals, https://www.aristopharma.com/products/silodosin-api.php
3. "Silodosin API Suppliers" - Ami Organics, https://www.amiorganics.in/products/silodosin
4. "Silodosin: MedlinePlus Drug Information" - National Institutes of Health, https://medlineplus.gov/druginfo/meds/a608014.html
5. "Active Pharmaceutical Ingredients (APIs)" - U.S. Food and Drug Administration, https://www.fda.gov/drugs/pharmaceutical-quality-resources/active-pharmaceutical-ingredients-apis
6. "Silodosin Patent Expiry" - DrugPatentWatch.com, https://drugpatentwatch.com/
7. "Patent Challenges and Generic Drug Entry" - U.S. Food and Drug Administration, https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/patent-challenges-and-generic-drug-entry
8. "Silodosin" - Drugs.com, https://www.drugs.com/silodosin.html
9. "About CDSCO" - Central Drugs Standard Control Organisation, https://cdsco.gov.in/opencms/opencms/en/About-CDSCO/